Pembrolizumab

Cat. No.: PI1374853914

Description: Pembrolizumab belongs to the group of monoclonal antibodies. The active ingredient prevents the inhibition of T cells. It is used for the treatment of metastatic carcinomas.

Product Details

CAS	1374853-91-4
Product Status	Development
Molecular Size	Large
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .